Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse. - Wikidata - wikimedia - TriplyDB

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

http://www.wikidata.org/entity/Q36464551

about

Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?Limited effects of an eIF2αS51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's disease.Complete morphologies of basal forebrain cholinergic neurons in the mouse.Phospho-eIF2α level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice Functional deprivation promotes amyloid plaque pathogenesis in Tg2576 mouse olfactory bulb and piriform cortex.Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: implications for neuritic plaque development A small molecule p75NTR ligand, LM11A-31, reverses cholinergic neurite dystrophy in Alzheimer's disease mouse models with mid- to late-stage disease progression.Cholinotrophic basal forebrain system alterations in 3xTg-AD transgenic mice.Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer's Disease.Specific serotonergic denervation affects tau pathology and cognition without altering senile plaques deposition in APP/PS1 mice.DHA diet reduces AD pathology in young APPswe/PS1 Delta E9 transgenic mice: possible gender effects IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.Cattle encephalon glycoside and ignotin injection improves cognitive impairment in APPswe/PS1dE9 mice used as multitarget anti-Alzheimer's drug candidates Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.Basal forebrain cholinergic modulation of sleep transitions Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice Beta-amyloid deposition and functional impairment in the retina of the APPswe/PS1DeltaE9 transgenic mouse model of Alzheimer's disease.Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in Alzheimer's disease, but does extend lifespan.BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.Amyloid-beta expression in retrosplenial cortex of triple transgenic mice: relationship to cholinergic axonal afferents from medial septum.Neuroprotective role for galanin in Alzheimer's disease.Intrinsic Cholinergic Neurons in the Hippocampus: Fact or Artifact?The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease.Rapid β-amyloid deposition and cognitive impairment after cholinergic denervation in APP/PS1 mice.Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer's Disease.Early Tau pathology involving the septo-hippocampal pathway in a Tau transgenic model: relevance to Alzheimer's disease.Neuroprotective Actions of Dietary Choline.Exogenous galanin attenuates spatial memory impairment and decreases hippocampal β-amyloid levels in rat model of Alzheimer's disease.Cholinergic profiles in the Goettingen miniature pig (Sus scrofa domesticus) brain.GABA transmission via ATP-dependent K+ channels regulates α-synuclein secretion in mouse striatum.Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion.Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.

P2860

Q24601893-6B643769-B1A6-40AE-A214-CDA85E919F74 Q30637868-2535F40B-7555-45EB-87ED-9CF8F22E0D7E Q33687237-585F5BE1-E5FF-4BDE-8318-F275F6C0E31C Q33707706-69714C71-33A6-41FE-9963-863FCD1CF620 Q33818653-CC04ED00-4E15-4747-BF42-1A6512DB29E9 Q33849442-11CB01E9-4853-437B-8474-7D07D6BA1857 Q34083364-FDC475D6-56AC-4F83-A1BA-395C6B7C10E0 Q34459388-8DC3ED4A-8C3C-4503-8AAE-BE8F9D073FA1 Q34488847-3F824EEA-5CB3-47EB-80E4-67CF6913D58A Q35053378-02EADF1E-EC50-42C2-8B7C-03FB842E0495 Q35053868-51AD4FC2-B679-439C-AAE1-96849589DF59 Q35147651-53DF9147-98C1-4B32-8D52-130E5E00469F Q35167977-ED01D5C6-3C85-4D76-997A-86DFDA0D8AB1 Q35634147-5E215756-0117-4AB9-9B80-31C638FF1964 Q35838504-9053EECC-0EFB-4173-951F-36C683E9B733 Q35993648-6CC972F3-35D9-4721-9195-7D63FE392C78 Q36254038-732E7D0F-9052-4640-B5AA-5FECCDBE708E Q36968718-23AB62E8-4426-465F-A84D-88F8E8E9502D Q37117543-C103A18A-2AB1-4324-B945-B29B98075507 Q37353095-2F0FF011-BAF2-43FC-BE5C-23AB0F949DC1 Q37442426-C4C3D8C7-5A6C-4567-8D95-E582AE8139A5 Q37836750-CB70F491-80B3-4693-93FD-A382163DF335 Q38886038-F37BD076-FF09-4BDF-88C1-36C28350CA40 Q39381722-8F80231E-9805-41BF-BDA2-1CA6534136BF Q39460000-A15ECFB5-6793-44B8-A867-A34B2E2CC23B Q39767994-D78B1C6B-081A-485B-B878-B635BA2DA5D6 Q40181559-9E34ED1C-DBDF-4F4D-A181-0C2E5B9F5746 Q41583852-AF855677-54BE-4A3F-AC2F-7F628346FEE6 Q44260000-87B3D3A5-D90F-4CE1-9EAC-FFE2BFAA1E60 Q46506295-414DD637-C0A5-46C3-9065-2D4A19D38B09 Q46590384-6416BF40-F886-42BE-B833-E7D48F454B31 Q50531667-EED13CD9-DEE4-433D-9F8D-28812A470649 Q50615160-5DA135C4-4BAF-4B33-8E46-06E1B3A2E851 Q54977834-5EA35BEE-63D2-43EC-BCA4-B1784E3164AB

P2860

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

http://www.wikidata.org/entity/Q36464551

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

@ast

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

@en

type

label

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

@ast

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

@en

prefLabel

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

@ast

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse.

@en

P1433

Q36464551-C223715B-B570-4644-85F8-C2EF0922BA84

P1476

Q36464551-0341B7F8-478B-4D09-896C-29F23B801F64

P2093

Q36464551-15A2D8E6-C396-48FD-BD1D-166609443FCF

Q36464551-2F125AE7-BB68-4819-9122-9632D86DCD91

Q36464551-49BF0DA3-890A-4863-B7D1-62F84893734C

Q36464551-921FE839-A7C5-4659-BD7C-B16AEA45948D

P2860

Q36464551-07393BFE-63FE-4B5D-BC78-F7CC006877E1

Q36464551-07EFCEAC-DD2E-42BE-B62C-8BD5F08760B3

Q36464551-0E15A07A-3E7A-4AD8-989C-6081E42AD02B

Q36464551-0E74A65E-DCF9-48D9-8977-B7680D0E0DE1

Q36464551-0F404184-F9D1-4C61-976F-9318CC905A4C

Q36464551-105F6FF9-B880-48B4-9D54-39186D121FC8

Q36464551-115EDC2B-FBE1-40F2-9398-A0903727C921

Q36464551-11D3EAEB-A8E6-4C33-9B2E-F32366B4AE37

Q36464551-12644DF2-9BF7-43AB-BE1A-B3EC48148A69

Q36464551-1765386E-5138-41C9-A0C7-7989934E6C9C

P304

Q36464551-C8676CBD-4C85-40CB-B5F9-8FF295F1AEEC

P31

Q36464551-88163A44-FFE8-4305-892C-8EA17588B4E7

P356

Q36464551-FC5ACF82-BB51-4B91-9A61-89B295B9BF0A

P433

Q36464551-DC69924D-3E8A-4B28-BF11-9E9388B9472A

P478

Q36464551-961C5695-A492-4EAD-9A12-2789977DA01A

P50

Q36464551-87C167B5-D001-40E9-9C75-5BE0967C09EC

P577

Q36464551-1366D109-2099-4310-AD76-5ADE3C903E91

P5875

Q36464551-D94C30F9-D1F1-4A4B-A964-E2CCBF1AAE53

P698

Q36464551-72CA98E5-EB10-42AC-AAA0-2B1893B9C80C

P932

Q36464551-2229527B-2CDD-4E34-B76C-F485C4104271

P356

J.NBD.2007.06.015

P1433

Neurobiology of Disease

P1476

Cholinergic forebrain degeneration in the APPswe/PS1DeltaE9 transgenic mouse

@en

P2093

Elliott J Mufson

http://www.w3.org/2001/XMLSchema#string

Milos D Ikonomovic

http://www.w3.org/2001/XMLSchema#string

Saleem Dar

http://www.w3.org/2001/XMLSchema#string

Sylvia E Perez

http://www.w3.org/2001/XMLSchema#string

P2860

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

Neuropathological stageing of Alzheimer-related changes

Alzheimer's disease: genes, proteins, and therapy

Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport

Induction of autophagy in axonal dystrophy and degeneration

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease.

Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis.

P304

3-15

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NBD.2007.06.015

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Steven T Dekosky

P577

2007-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6175768

http://www.w3.org/2001/XMLSchema#string

P698

17662610

http://www.w3.org/2001/XMLSchema#string

P932

2245889

http://www.w3.org/2001/XMLSchema#string